Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency

English version České info

Herpesviruses establish a lifelong latent infection posing the risk for virus reactivation and disease. In cytomegalovirus infection, expression of the major immediate early (IE) genes is a critical checkpoint, driving the lytic replication cycle upon primary infection or reactivation from latency. While it is known that type I interferon (IFN) limits lytic CMV replication, its role in latency and reactivation has not been explored. In the model of mouse CMV infection, we show here that IFNβ blocks mouse CMV replication at the level of IE transcription in IFN-responding endothelial cells and fibroblasts. The IFN-mediated inhibition of IE genes was entirely reversible, arguing that the IFN-effect may be consistent with viral latency. Importantly, the response to IFNβ is stochastic, and MCMV IE transcription and replication were repressed only in IFN-responsive cells, while the IFN-unresponsive cells remained permissive for lytic MCMV infection. IFN blocked the viral lytic replication cycle by upregulating the nuclear domain 10 (ND10) components, PML, Sp100 and Daxx, and their knockdown by shRNA rescued viral replication in the presence of IFNβ. Finally, IFNβ prevented MCMV reactivation from endothelial cells derived from latently infected mice, validating our results in a biologically relevant setting. Therefore, our data do not only define for the first time the molecular mechanism of IFN-mediated control of CMV infection, but also indicate that the reversible inhibition of the virus lytic cycle by IFNβ is consistent with the establishment of CMV latency.

Vyšlo v časopise: Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency. PLoS Pathog 10(2): e32767. doi:10.1371/journal.ppat.1003962
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003962

Souhrn

Zdroje

1. WellerTH (1970) Review. Cytomegaloviruses: the difficult years. J Infect Dis 122 : 532–539.

2. Mocarski EJ, Shenk T, Pass RS (2007) Cytomegaloviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, editors. Fields Virology. 5th ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins. pp. 2701–2773.

3. RazonableRR, PayaCV (2002) The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation. Liver Transpl 8 : 651–658.

4. ReddehaseMJ, SimonCO, SeckertCK, LemmermannN, GrzimekNK (2008) Murine model of cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 325 : 315–331.

5. BrautigamAR, DutkoFJ, OldingLB, OldstoneMBA (1979) Pathogenesis of Murine Cytomegalo-Virus Infection -⁠ Macrophage as a Permissive Cell for Cytomegalo-Virus Infection, Replication and Latency. Journal of General Virology 44 : 349–359.

6. SinzgerC, GrefteA, PlachterB, GouwASH, TheTH, et al. (1995) Fibroblasts, Epithelial-Cells, Endothelial-Cells and Smooth-Muscle Cells Are Major Targets of Human Cytomegalovirus-Infection in Lung and Gastrointestinal Tissues. Journal of General Virology 76 : 741–750.

7. PollockJL, PrestiRM, PaetzoldS, VirginHWt (1997) Latent murine cytomegalovirus infection in macrophages. Virology 227 : 168–179.

8. HahnG, JoresR, MocarskiES (1998) Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 95 : 3937–3942.

9. GoodrumFD, JordanCT, HighK, ShenkT (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci U S A 99 : 16255–16260.

10. ReevesM, SinclairJ (2008) Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 325 : 297–313.

11. PampouSY, GnedoySN, BystrevskayaVB, SmirnovVN, ChazovEI, et al. (2000) Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta. Virchows Archiv-an International Journal of Pathology 436 : 539–552.

12. ReevesMB, ColemanH, ChaddertonJ, GoddardM, SissonsJGP, et al. (2004) Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in Vivo. Journal of General Virology 85 : 3337–3341.

13. SeckertCK, RenzahoA, TervoHM, KrauseC, DeegenP, et al. (2009) Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol 83 : 8869–8884.

14. LiuXF, YanSX, AbecassisM, HummelM (2010) Biphasic Recruitment of Transcriptional Repressors to the Murine Cytomegalovirus Major Immediate-Early Promoter during the Course of Infection In Vivo. J Virol 84 : 3631–3643.

15. LiuXF, YanSX, AbecassisM, HummelM (2008) Establishment of Murine Cytomegalovirus Latency In Vivo Is Associated with Changes in Histone Modifications and Recruitment of Transcriptional Repressors to the Major Immediate-Early Promoter. J Virol 82 : 10922–10931.

16. MocarskiES (2007) Betaherpes viral genes and their functions. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis 204–230.

17. ReevesMB, MacAryPA, LehnerPJ, SissonsJG, SinclairJH (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102 : 4140–4145.

18. VermaS, WangQ, ChodaczekG, BenedictCA (2013) Lymphoid tissue stromal cells coordinate innate defense to cytomegalovirus. J Virol 87 : 6201–10.

19. PrestiRM, PollockJL, Dal CantoAJ, O'GuinAK, VirginHWt (1998) Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 188 : 577–588.

20. SadlerAJ, WilliamsBR (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8 : 559–568.

21. BenedictCA, BanksTA, SenderowiczL, KoM, BrittWJ, et al. (2001) Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus detente. Immunity 15 : 617–626.

22. KroppKA, RobertsonKA, SingG, Rodriguez-MartinS, BlancM, et al. (2011) Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-gamma) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state. J Virol 85 : 10286–10299.

23. DagF, WeingartnerA, ButuevaM, ConteI, HolzkiJ, et al. (2013) A new reporter mouse cytomegalovirus reveals maintained immediate-early gene expression but poor virus replication in cycling liver sinusoidal endothelial cells. Virol J 10 : 197.

24. RandU, RinasM, SchwerkJ, NohrenG, LinnesM, et al. (2012) Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response. Mol Syst Biol 8 : 584.

25. BuscheA, AnguloA, Kay-JacksonP, GhazalP, MesserleM (2008) Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med Microbiol Immunol 197 : 233–240.

26. StinskiMF, IsomuraH (2008) Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med Microbiol Immunol 197 : 223–231.

27. MesserleM, CrnkovicI, HammerschmidtW, ZieglerH, KoszinowskiUH (1997) Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A 94 : 14759–14763.

28. BresnahanWA, ShenkT (2000) A subset of viral transcripts packaged within human cytomegalovirus particles. Science 288 : 2373–2376.

29. MarcinowskiL, LidschreiberM, WindhagerL, RiederM, BosseJB, et al. (2012) Real-time transcriptional profiling of cellular and viral gene expression during lytic cytomegalovirus infection. PLoS Pathog 8: e1002908.

30. WoodhallDL, GrovesIJ, ReevesMB, WilkinsonG, SinclairJH (2006) Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem 281 : 37652–37660.

31. TavalaiN, PapiorP, RechterS, LeisM, StammingerT (2006) Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80 : 8006–8018.

32. TavalaiN, PapiorP, RechterS, StammingerT (2008) Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82 : 126–137.

33. GuldnerHH, SzosteckiC, GrotzingerT, WillH (1992) IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol 149 : 4067–4073.

34. Chelbi-AlixMK, PelicanoL, QuignonF, KokenMH, VenturiniL, et al. (1995) Induction of the PML protein by interferons in normal and APL cells. Leukemia 9 : 2027–2033.

35. PulvererJE, RandU, LienenklausS, KugelD, ZietaraN, et al. (2010) Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol 84 : 8626–8638.

36. LienenklausS, CornitescuM, ZietaraN, LyszkiewiczM, GekaraN, et al. (2009) Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J Immunol 183 : 3229–3236.

37. StinskiMF, ThomsenDR, RodriguezJE (1982) Synthesis of human cytomegalovirus-specified RNA and protein in interferon-treated cells at early times after infection. J Gen Virol 60 : 261–270.

38. GribaudoG, RavagliaS, CaliendoA, CavalloR, GariglioM, et al. (1993) Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197 : 303–311.

39. PaulusC, KraussS, NevelsM (2006) A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A 103 : 3840–3845.

40. HuhYH, KimYE, KimET, ParkJJ, SongMJ, et al. (2008) Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J Virol 82 : 10444–10454.

41. TangQ, MaulGG (2003) Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J Virol 77 : 1357–1367.

42. IshovAM, MaulGG (1996) The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134 : 815–826.

43. TavalaiN, StammingerT (2008) New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta 1783 : 2207–2221.

44. GlassM, EverettRD (2013) Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. J Virol 87 : 2174–2185.

45. LiH, LeoC, ZhuJ, WuX, O'NeilJ, et al. (2000) Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol 20 : 1784–1796.

46. MichaelsonJS, LederP (2003) RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX. J Cell Sci 116 : 345–352.

47. NegorevDG, VladimirovaOV, MaulGG (2009) Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation. J Virol 83 : 5168–5180.

48. CheeAV, LopezP, PandolfiPP, RoizmanB (2003) Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol 77 : 7101–7105.

49. GariglioM, MartinottiMG, CavalloG, LandolfoS (1990) Regulation of gene expression by interferons. G Batteriol Virol Immunol 83 : 143–149.

50. MullerU, SteinhoffU, ReisLF, HemmiS, PavlovicJ, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264 : 1918–1921.

51. de WeerdNA, VivianJP, NguyenTK, ManganNE, GouldJA, et al. (2013) Structural basis of a unique interferon-beta signaling axis mediated via the receptor IFNAR1. Nat Immunol 14 : 901–907.

52. AsanoM, HayashiM, YoshidaE, KawadeY, IwakuraY (1990) Induction of interferon-alpha by interferon-beta, but not of interferon-beta by interferon-alpha, in the mouse. Virology 176 : 30–38.

53. PolicB, HengelH, KrmpoticA, TrgovcichJ, PavicI, et al. (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188 : 1047–1054.

54. HoltappelsR, Pahl-SeibertMF, ThomasD, ReddehaseMJ (2000) Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74 : 11495–11503.

55. Podlech J, Holtappels R, Grzimek NKA, and Reddehase MJ. (2002) Animal models: murine cytomegalovirus. . In: Kabelitz SHEKaD, editor. Methods in microbiology. San Diego, CA: Academic Press. pp. 493–525.

56. ReddehaseMJ, KeilGM, KoszinowskiUH (1984) The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. J Immunol 132 : 482–489.

57. JordanSJK, PragerA, MitrovicM, JonjicS, KoszinowskiUH, AdlerB (2011) Virus Progeny of Murine Cytomegalovirus Bacterial Artificial Chromosome pSM3fr Show Reduced Growth in Salivary Glands due to a Fixed Mutation of MCK-2. Journal of Virology 85 : 10346–10353.

58. BubicI, WagnerM, KrmpoticA, SauligT, KimS, et al. (2004) Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78 : 7536–7544.

59. DolkenL, KrmpoticA, KotheS, TuddenhamL, TanguyM, et al. (2010) Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog 6: e1001150.

60. RawlinsonWD, FarrellHE, BarrellBG (1996) Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70 : 8833–8849.

61. DaltonKP, RoseJK (2001) Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology 279 : 414–421.

62. AdlerH, MesserleM, WagnerM, KoszinowskiUH (2000) Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74 : 6964–6974.

63. WahlC, BochtlerP, SchirmbeckR, ReimannJ (2007) Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes. J Immunol 178 : 2083–2093.

64. LiH, DurbinR (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25 : 1754–1760.

65. R Development Core Team (2005) R: A language and environment for statistical computing, reference index version 2.x.x. Vienna, Austria: R Foundation for Statistical Computing.

66. RobinsonMD, McCarthyDJ, SmythGK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26 : 139–140.